| Purespring Therapeutics to present new data on pipeline progress in Alport Syndrome at the American Society of Nephrology (ASN) Kidney Week 2026 |
Globe Newswire |
10/14 |
07:19 |
| TTM Technologies, Inc. to Conduct Third Quarter 2026 Conference Call on October 22, 2026 |
Globe Newswire |
10/14 |
07:17 |
| Invivyd and the SPEAR Study Group Announce Initiation of “FLINTLOCK” Phase 2 Study of VYD2311, a Monoclonal Antibody for the Potential Treatment of Long COVID or Post-Vaccination Syndrome |
Globe Newswire |
10/14 |
07:01 |
| BreathiZen Introduces BreathiZen Spray With Mullein Leaf Extract, Ginger Root Extract, Bromelain, and Organic Lemon Extract 60 ml |
Globe Newswire |
10/14 |
07:00 |
| Entrada Therapeutics Announces Positive Results from the First Cohort of Participants with Duchenne Muscular Dystrophy (DMD) in the Phase 1/2 ELEVATE-45-201 Study of ENTR-601-45 |
Globe Newswire |
10/14 |
07:00 |
| Minuteman Press Franchise Owner Eric Burrill Celebrates 8 Years & Grows Family Business in Avondale Estates, GA |
Globe Newswire |
10/14 |
07:00 |
| Arexera Therapeutics, Formerly Atalanta Therapeutics, Unveils New Corporate Identity and Advances Huntington's Disease Franchise |
Globe Newswire |
10/14 |
07:00 |
| As Commercial Payments Slow, the Right Contact Can Change |
Globe Newswire |
10/14 |
07:00 |
| Parabilis Medicines Initiates Dose-Ranging Clinical Study of Zolucatetide in Familial Adenomatous Polyposis |
Globe Newswire |
10/14 |
07:00 |
| Independent Safety Data Monitoring Committee Recommends Initiation of Cohort 3 at the Top Dose of 18 mg/kg in Entrada Therapeutics’ ELEVATE-44-201 Study |
Globe Newswire |
10/14 |
07:00 |
| Peoples, Ltd. Begins Trading on OTCQX Best Market |
Globe Newswire |
10/14 |
07:00 |
| Ridgepost Capital to Announce Third Quarter 2026 Financial Results and Host Investor Call |
Globe Newswire |
10/14 |
07:00 |
| Macerich Schedules Third Quarter 2026 Earnings Release and Conference Call |
Globe Newswire |
10/14 |
07:00 |
| DMC Global to Report Third Quarter Financial Results on October 27, 2026 |
Globe Newswire |
10/14 |
07:00 |
| Aya Gold & Silver Reports Record Q3-2026 Production of 2.03 Million AgEq Ounces |
Globe Newswire |
10/14 |
07:00 |
| Climb adds Netwrix to its Security Portfolio, Bringing Data and Identity Security to VARs and MSPs |
Globe Newswire |
10/14 |
07:00 |
| Yukon Metals Confirms New Copper-Gold-Molybdenum Porphyry-Style System at Viper Prospect, AZ Project |
Globe Newswire |
10/14 |
07:00 |
| Seyond to Showcase Live LiDAR Operational Twin Demo at Dell Technologies and NVIDIA Booth at Smart City Expo World Congress 2026 |
Globe Newswire |
10/14 |
07:00 |
| Sono-Tek Reports Fiscal Second Quarter and First Half 2027 Results Driven by Strong Medical Sector and Higher Value Production Systems |
Globe Newswire |
10/14 |
07:00 |
| PyroGenesis Receives $860,000 Down Payment for Recently Announced Two-Torch Contract with European Mining, Metallurgy & Materials Client |
Globe Newswire |
10/14 |
07:00 |
| Alpha Compute Signs Binding GPU Contract, Leasing ALPHA-03 cluster under Four-Year, $81.7 Million Agreement in its Missouri Superintelligence Factory |
Globe Newswire |
10/14 |
07:00 |
| Elion Therapeutics Expands Pipeline with Exclusive Global License to Inhaled Antifungal for Immunocompromised Patients |
Globe Newswire |
10/14 |
07:00 |
| YieldMax® ETFs Announces Weekly Distributions for Group 2 ETFs |
Globe Newswire |
10/14 |
06:55 |
| Garrett Motion to Hold Third Quarter 2026 Financial Results Conference Call on Thursday October 29th, 2026 |
Globe Newswire |
10/14 |
06:55 |
| Eton Pharmaceuticals and Aquestive Therapeutics Announce Exclusive U.S. Licensing Agreement for LIBERVANT® (diazepam) Buccal Film |
Globe Newswire |
10/14 |
06:50 |
